FDA Application
-
NDC Search Results on Active Ingredient: codeine
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ACETAMINOPHEN; CODEINE PHOSPHATE | 53489-160-05 | Mutual Pharmaceutical Company, Inc. | ANDA089672 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 53489-160-01 | Mutual Pharmaceutical Company, Inc. | ANDA089672 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 53489-159-01 | Mutual Pharmaceutical Company, Inc. | ANDA089671 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ASPIRIN; BUTALBITAL; CAFFEINE | 0722-6094-05 | Nexgen Pharma, Inc. | ANDA075231 | HUMAN PRESCRIPTION DRUG | ANDA |
CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE | 0722-7184-01 | Nexgen Pharma, Inc. | NDA206323 | HUMAN PRESCRIPTION DRUG | NDA |
BUTALBITAL; ACETAMINOPHEN; CODEINE PHOSPHATE; CAFFEINE | 0722-6670-01 | Nexgen Pharma, Inc. | ANDA076560 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ASPIRIN; BUTALBITAL; CAFFEINE | 0722-6094-01 | Nexgen Pharma, Inc. | ANDA075231 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; BUTALBITAL; CODEINE PHOSPHATE; CAFFEINE | 0722-7028-05 | Nexgen Pharma, Inc. | ANDA076560 | HUMAN PRESCRIPTION DRUG | ANDA |
BUTALBITAL; ACETAMINOPHEN; CODEINE PHOSPHATE; CAFFEINE | 0722-6670-05 | Nexgen Pharma, Inc. | ANDA076560 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; BUTALBITAL; CODEINE PHOSPHATE; CAFFEINE | 0722-7028-01 | Nexgen Pharma, Inc. | ANDA076560 | HUMAN PRESCRIPTION DRUG | ANDA |
GUAIFENESIN; CODEINE PHOSPHATE | 70156-112-04 | Noble Pharmaceuticals, LLC | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-52 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-87 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-54 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-53 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-910-54 | Northwind Pharmaceuticals, LLC | ANDA211610 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 51655-802-54 | Northwind Pharmaceuticals, LLC | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 51655-802-53 | Northwind Pharmaceuticals, LLC | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE | 70408-185-34 | Nostrum Laboratories, Inc. | ANDA090180 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE | 70408-185-31 | Nostrum Laboratories, Inc. | ANDA090180 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 68071-3100-2 | NuCare Pharmaceuticals, Inc. | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 68071-3100-8 | NuCare Pharmaceuticals, Inc. | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 68071-3100-4 | NuCare Pharmaceuticals, Inc. | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 68071-3061-2 | NuCare Pharmaceuticals, Inc. | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 68071-3100-3 | NuCare Pharmaceuticals, Inc. | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 68071-3061-6 | NuCare Pharmaceuticals, Inc. | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 68071-3100-6 | NuCare Pharmaceuticals, Inc. | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 68071-3061-4 | NuCare Pharmaceuticals, Inc. | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 68071-3100-5 | NuCare Pharmaceuticals, Inc. | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 68071-4475-4 | NuCare Pharmaceuticals,Inc. | ANDA040419 | HUMAN PRESCRIPTION DRUG | ANDA |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
301-330 | 331-360 | 361-390 | 391-420 | 421-450 | 451-480 | 481-510 | 511-540 | 541-570 | 571-600 |
601-630 | 631-660 | 661-690 | 691-720 | 721-750 | 751-753 |
-